TY - JOUR
T1 - Antibacterial activity of (±) 6-benzyl-1-(3-carboxypropyl) indane; a possible way to identify leading novel anti-H. pylori Agents
AU - Numao, Naganori
AU - Hirota, Yukiko
AU - Iwahori, Akiyo
AU - Sasatsu, Masanori
AU - Kondo, Isamu
AU - Takao, Ken Ichi
AU - Kobayashi, Susumu
PY - 1997/1/1
Y1 - 1997/1/1
N2 - Magainin 2, isolated from the skin of the Xenopus laevis, is an antimicrobial peptide which reacts directly with the biological membrane to lyse various bacteria from negative and positive microorganisms. In a previous report, we showed that (±)1-(4-aminobutyl)-6-benzylindane (PM2), which mimicked the conformation of the side-chains of a complementary unit on the amino acid sequence of magainin 2 analogs, expressed the in vitro antibacterial activity not only against Helicobacter. pylori (ATCC43526, ATCC43579), but also against Escherichia coli (ATCC25922) and Staphylococcus aureus (ATCC25923). In addition, PM2 caused human blood red cells (RBCs) to lyse at the minimum inhibitory concentration (MIC) value. Based on the antibacterial activities of 9-phenylnonanoic acid (pC9c), we further synthesized (±)-6-benzyl-1-(3-carboxypropyl) indane (PM2c), which replaced a positive charge of PM2 with a negative one, and tested the biological activities. PM2c had the ability to inhibit the growth of H. pylori strains, but its activity to inhibit the growth of E. coli and S. aureus was not detected and weak, respectively. Moreover, PM2c showed non-hemolytic activity against RBCS at the MIC value. These results indicate the possibility that PM2c may be more useful than PM2 either alone or in combination with well- known therapeutic agents for the treatment of H. pylori infection.
AB - Magainin 2, isolated from the skin of the Xenopus laevis, is an antimicrobial peptide which reacts directly with the biological membrane to lyse various bacteria from negative and positive microorganisms. In a previous report, we showed that (±)1-(4-aminobutyl)-6-benzylindane (PM2), which mimicked the conformation of the side-chains of a complementary unit on the amino acid sequence of magainin 2 analogs, expressed the in vitro antibacterial activity not only against Helicobacter. pylori (ATCC43526, ATCC43579), but also against Escherichia coli (ATCC25922) and Staphylococcus aureus (ATCC25923). In addition, PM2 caused human blood red cells (RBCs) to lyse at the minimum inhibitory concentration (MIC) value. Based on the antibacterial activities of 9-phenylnonanoic acid (pC9c), we further synthesized (±)-6-benzyl-1-(3-carboxypropyl) indane (PM2c), which replaced a positive charge of PM2 with a negative one, and tested the biological activities. PM2c had the ability to inhibit the growth of H. pylori strains, but its activity to inhibit the growth of E. coli and S. aureus was not detected and weak, respectively. Moreover, PM2c showed non-hemolytic activity against RBCS at the MIC value. These results indicate the possibility that PM2c may be more useful than PM2 either alone or in combination with well- known therapeutic agents for the treatment of H. pylori infection.
KW - Combinatorial chemistry
KW - Complementary peptidomimetic
KW - H. pylori
KW - Indane derivative
KW - Magainin 2
KW - Selective activity
UR - http://www.scopus.com/inward/record.url?scp=0031283084&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031283084&partnerID=8YFLogxK
U2 - 10.1248/bpb.20.1204
DO - 10.1248/bpb.20.1204
M3 - Article
C2 - 9401733
AN - SCOPUS:0031283084
SN - 0918-6158
VL - 20
SP - 1204
EP - 1207
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 11
ER -